Insufficient scRNA-seq data for expression of PFKFB4 at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 644.60 | 2623 / 2642 | 100% | 12.05 | 703 / 705 |
prostate | 98% | 664.16 | 240 / 245 | 97% | 6.62 | 489 / 502 |
pancreas | 100% | 1049.73 | 328 / 328 | 95% | 6.57 | 169 / 178 |
ovary | 97% | 544.63 | 175 / 180 | 95% | 9.37 | 410 / 430 |
skin | 96% | 622.05 | 1743 / 1809 | 96% | 22.45 | 454 / 472 |
lung | 99% | 768.10 | 575 / 578 | 92% | 9.46 | 1062 / 1155 |
uterus | 94% | 365.47 | 160 / 170 | 97% | 12.25 | 445 / 459 |
kidney | 99% | 532.67 | 88 / 89 | 85% | 11.73 | 770 / 901 |
bladder | 86% | 343.71 | 18 / 21 | 98% | 11.32 | 495 / 504 |
adrenal gland | 88% | 376.10 | 228 / 258 | 90% | 9.54 | 208 / 230 |
intestine | 86% | 581.86 | 830 / 966 | 90% | 8.02 | 476 / 527 |
thymus | 94% | 309.92 | 611 / 653 | 79% | 2.90 | 475 / 605 |
breast | 73% | 297.07 | 333 / 459 | 98% | 8.11 | 1094 / 1118 |
esophagus | 74% | 510.00 | 1069 / 1445 | 88% | 7.20 | 161 / 183 |
stomach | 53% | 137.81 | 192 / 359 | 82% | 5.98 | 234 / 286 |
peripheral blood | 100% | 7759.31 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 1805.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.59 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.58 | 1 / 1 |
blood vessel | 80% | 292.11 | 1069 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 4.49 | 22 / 29 |
adipose | 61% | 213.45 | 738 / 1204 | 0% | 0 | 0 / 0 |
liver | 27% | 110.23 | 62 / 226 | 29% | 1.60 | 116 / 406 |
eye | 0% | 0 | 0 / 0 | 36% | 1.52 | 29 / 80 |
muscle | 34% | 91.01 | 271 / 803 | 0% | 0 | 0 / 0 |
heart | 27% | 85.02 | 236 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006000 | Biological process | fructose metabolic process |
GO_0046835 | Biological process | carbohydrate phosphorylation |
GO_0006003 | Biological process | fructose 2,6-bisphosphate metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0004331 | Molecular function | fructose-2,6-bisphosphate 2-phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003873 | Molecular function | 6-phosphofructo-2-kinase activity |
Gene name | PFKFB4 |
Protein name | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 4 isoform 1 (EC 2.7.1.105, EC 3.1.3.46) (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (6PF-2-K/Fru-2,6-P2ase 4) (PFK/FBPase 4) (6PF-2-K/Fru-2,6-P2ase testis-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] |
Synonyms | |
Description | FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate. |
Accessions | ENST00000452531.5 ENST00000416568.5 F8WC12 C9JJ23 F8WDY1 Q66S35 ENST00000417753.5 ENST00000445633.5 Q16877 ENST00000422701.1 C9K0D8 C9JX77 ENST00000232375.8 [Q16877-1] ENST00000383734.6 [Q16877-2] ENST00000412035.5 |